Coronavirus

COVID antibody treatment loses FDA authorization

Bottles holding a two-shot dose of AstraZeneca's Evusheld, the first set of antibodies grown in a lab to prevent COVID-19, rest on a table on Jan. 20, 2022 at a University of Washington Medicine clinic in Seattle. (Ted S. Warren/Associated Press)

Top Coronavirus Headlines

Could a ‘morning after’ nasal spray fight COVID?

Could fat cells be playing a role in long COVID?

Long COVID

CDC urges masking return as tripledemic surges

Omicron drives latest COVID-19 surge, holiday worries

Carey Johnson, Fabian Swain

Masks could return as COVID cases rise in L.A. County

Baby was sick as Respiratory Syncytial Virus (RSV) in kid hospital. Thai little girl having inhaler containing medicine for stop coughing and disease flu.

Why you may soon have to pay for that COVID test

COVID-19 and flu vaccines files are seen at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines on Oct. 28, 2022, in Lynwood. (Mark J. Terrill/Associated Press)

More Coronavirus

Felt sick after COVID shot? That’s good

A nurse prepares a syringe of a COVID-19 vaccine at an inoculation station in Jackson, Miss., on July 19, 2022. (Rogelio V. Solis/Associated Press)

Main COVID symptoms have changed, research shows

How to tell the difference between strep throat, …

End date announced for COVID-19 ‘State of Emergency’

UCSF team finds key to asymptomatic COVID patients

Pfizer COVID vaccine 73% effective in kids under …

Director says CDC must ‘do better’ after COVID review

Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention, is seen during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the federal government’s response and future planning for COVID-19 on June 16, 2022. (Greg Nash/The Hill)